Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Can We Predict How Often Nephrotic Syndrome will Relapse into the Patients?

신증후군에서 스테로이드 반응성과 재발할 환자를 예측할 수 있을까?

  • 남궁미경 (연세대학교 원주의과대학 소아과학교실)
  • Received : 2005.09.23
  • Accepted : 2005.09.26
  • Published : 2005.10.15
Download PDF
⟨ Previous Next ⟩

Abstract

Pediatric nephrotic syndrome is a well-known illness for its high relapsing rate. If we can predict the relapsing rate and the responses to the steroid therapy of individual patients with nephrotic syndrome, the predictability will be helpful in building a therapeutic plan. Here is my review of research articles on the risk factors for the prediction of relapsing nephrotic syndrome.

Keywords

References

  1. Lahdenkari AT, Suvanto M, Kaskimies O, Kestila M, Jalanko H. Clinical features and outcome of childhood minimal change nephrotic syndrome : is genetics involved? Pediatr Nephrol 2005;20;1073-80 https://doi.org/10.1007/s00467-005-1965-y
  2. Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Longterm outcome for children with minimal change nephrotic syndrome. Lancet 1985;8425:368-70
  3. Koskimies O, Vilska J, Rapola J, Hallman N. Longterm outcome of primary nephrotic syndrome. Arch Dis Child 1982;7;544-8
  4. Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome : from toddlers to twenties. Lancet 1989;8632:255-9
  5. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadous MF, Landais P, et al. Steroid sensitive nephrotic syndrome : from childhood to adulthood. Am J Kidney Dis 2003;3:550-7
  6. Ruth EM. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 2005;147:202-7 https://doi.org/10.1016/j.jpeds.2005.03.050
  7. Ehrich JH, Brohdehl J. Long versus standard prednisone therapy for initial treatment of idopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 1993;152:357-61 https://doi.org/10.1007/BF01956754
  8. Chun MJ, Korbet SM, Schwartz MM, Leweis EJ. Focal segmental glomerulosclerosis in nephrotic adults : presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004;15:2169-77 https://doi.org/10.1097/01.ASN.0000135051.62500.97
  9. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, et al. Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90:3730-4 https://doi.org/10.1073/pnas.90.8.3730
  10. Levy F, Kristofic C, Heusser C, Brinkmann V. Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int Arch Allergy Immunol 1997:112:49-58 https://doi.org/10.1159/000237431
  11. Bacharier LB, Jabara H, Geha RS. Molecular mechanism of immunoglobulin E regulation. Int Arch Allergy Immunol 1998;115:257-69 https://doi.org/10.1159/000069456
  12. Cheung W, Wei CL, Seah CC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol 2004;19:627-32 https://doi.org/10.1007/s00467-004-1438-8
  13. Bassi C, Petrini C, Rizza V, Napodano P, Pararella M, Arrigo G, et al. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis : a pilot study. Am J Kidney Dis 2003;41:328-35 https://doi.org/10.1053/ajkd.2003.50040
  14. Bakr A, Shokeir M, El-Chenawi F, El-Husseni F, Abdel-Rahman A, El-Ashry R. Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol 2003;18:516-20
  15. Glassock RJ. Circulating permeability factors in the nephrotic syndrome : a fresh look at an old problem. J Am Soc Nephrol 2003;14:541-3 https://doi.org/10.1097/01.ASN.0000051640.04273.75
  16. Kobayashi Y, Arakawa H, Suzuki M, Takizawa T, Tokuyama K, Morikawa A. Polymorphism of IL-4 related genes in Japanese children with minimal change nephrotic syndrome. Am J Kidney Dis 2003;42:271-6 https://doi.org/10.1016/S0272-6386(03)00652-8
  17. Akhtar M, Al Mana h. Molecular basis of proteinuria. Adv Anat Pathol 2004;11:304-9 https://doi.org/10.1097/01.pap.0000146219.03058.ea
  18. Vincenti F, Ghiggerri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005;5:1179-85 https://doi.org/10.1111/j.1600-6143.2005.00968.x
  19. Ruf RG, Lichtenberger A, Karle Sm, Haas JP, Anacleto FE, Schultheiss M, et al. Patients with mutations in NPHS2(podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Sco Nephrol 2004;15:722-32 https://doi.org/10.1097/01.ASN.0000113552.59155.72
  20. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, Mc-Cready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein-nephritis mutated in congenital nephrotic syndrome. Mol Cell 1998;4:575-82
  21. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24:349-354 https://doi.org/10.1038/74166
  22. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding alphaactinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251-6 https://doi.org/10.1038/73456
  23. Winn MP, Conlon PJ, Lynn KL, Howell DN, Slotterbeck BD, Smith AH, et al. Linkage of a gene causing familial focal glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999;58:113-20 https://doi.org/10.1006/geno.1999.5828
  24. White RH. The familial nephrotic syndrome. 1. A European survey. Clin Nephrol 1973;1:215-9
  25. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, et al. Broadening the spectrum of disease related to podocin mutations. J Am Soc Nephrol 2003;14:1278-86 https://doi.org/10.1097/01.ASN.0000060578.79050.E0
  26. Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR, et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004;65:1026-30. https://doi.org/10.1111/j.1523-1755.2004.00479.x
  27. Ruf RG, Fuchshuber A, Karle SM, Lemainque A, Huck K, Wienker T, et al. Identification of the first gene locus(SSNS1) for steroid sensitive nephrotic syndrome on chromosome 2p. J Am So Nephrol 2003;14:1897-900 https://doi.org/10.1097/01.ASN.0000070070.03811.02
  28. Reise J, Gersdorff GV, Loos M, Oh M, Asanuma K, Giardino L, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113:1390-7
  29. Schmid H, Henger A, Cohen CD, Frach K, Grone HJ, Schlondorff D, et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric disease. J Am Soc Nephrol 2003;14:2958-66. https://doi.org/10.1097/01.ASN.0000090745.85482.06
  30. Carlotti AP, Franco PB, Elias LL, Facincani I, Costa EL, Foss N, et al. Glucocorticoid receptors, in vitro steroid sensitivity, and cytokine secretion in idiopathic nephrotic syndrome. Kidney Int 2004;65:403-8 https://doi.org/10.1111/j.1523-1755.2004.00392.x